道琼斯指数
52,415.58
涨跌
+54.0+0.10%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 +0.10%,标普 500 指数为 +0.66%,纳斯达克综合指数为 +1.29%。个股方面,2,544 只上涨、2,574 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 51 | Solid Biosciences Inc.SLDB | $6.16 | +7.23% | 937.47K | $659.97M | $3.79 - $11.45 | 0.00% |
| 52 | 4D Molecular Therapeutics, Inc.FDMT | $11.76 | +6.80% | 678.11K | $649.40M | $6.96 - $16.93 | 0.00% |
| 53 | Aura Biosciences, Inc.AURA | $6.24 | +1.05% | 347.79K | $646.60M | $4.73 - $9.54 | 0.00% |
| 54 | Attovia Therapeutics, Inc.ATTO | $14.40 | +4.11% | 251.28K | $631.36M | $12.94 - $28.00 | 0.00% |
| 55 | DBV Technologies S.A.DBVT | $10.03 | +1.30% | 533.60K | $630.41M | $8.63 - $26.18 | 0.00% |
| 56 | Candel Therapeutics, Inc.CADL | $8.20 | +6.48% | 649.60K | $627.07M | $4.35 - $14.00 | 0.00% |
| 57 | Ginkgo Bioworks Holdings, Inc.DNA | $11.29 | +14.17% | 2.18M | $625.28M | $5.37 - $18.22 | 0.00% |
| 58 | Entera Bio Ltd.ENTX | $3.07 | +7.69% | 91.91K | $533.94M | $0.91 - $4.20 | 0.00% |
| 59 | NRC HealthNRC | $21.57 | -3.47% | 51.67K | $486.12M | $11.32 - $23.68 | 0.03% |
| 60 | REGENXBIO Inc.RGNX | $6.55 | +0.15% | 735.14K | $432.39M | $5.46 - $16.19 | 0.00% |
| 61 | Allogene Therapeutics, Inc.ALLO | $1.25 | +2.89% | 13.73M | $430.14M | $1.04 - $4.46 | 0.00% |
| 62 | Zura Bio LimitedZURA | $4.26 | +20.08% | 4.02M | $408.62M | $3.25 - $7.44 | 0.00% |
| 63 | Tectonic Therapeutic, Inc.TECX | $20.32 | +2.48% | 136.53K | $397.26M | $15.52 - $39.53 | 0.00% |
| 64 | Eikon Therapeutics, Inc.EIKN | $5.54 | +1.26% | 484.86K | $393.24M | $5.44 - $17.40 | 0.00% |
| 65 | Editas Medicine, Inc.EDIT | $2.56 | +7.71% | 2.15M | $392.40M | $1.66 - $3.94 | 0.00% |
| 66 | C4 Therapeutics, Inc.CCCC | $3.17 | +7.55% | 3.24M | $390.60M | $1.69 - $5.17 | 0.00% |
| 67 | Fennec Pharmaceuticals Inc.FENC | $10.55 | +4.38% | 43.53K | $370.89M | $5.65 - $13.25 | 0.00% |
| 68 | IRulya Therapeutics Inc.IRLA | $32.58 | +5.31% | 123.10K | $353.17M | $25.13 - $41.00 | 0.00% |
| 69 | Surrozen, Inc.SRZN | $29.96 | +7.18% | 280.30K | $347.90M | $11.39 - $37.83 | 0.00% |
| 70 | Kyverna Therapeutics, Inc.KYTX | $5.60 | +6.93% | 579.88K | $346.32M | $5.15 - $13.67 | 0.00% |
| 71 | X4 Pharmaceuticals, Inc.XFOR | $3.29 | +1.23% | 1.32M | $325.70M | $2.43 - $4.83 | 0.00% |
| 72 | ProKidney Corp.PROK | $1.52 | +12.50% | 884.89K | $318.61M | $1.30 - $3.48 | 0.00% |
| 73 | Scribe Therapeutics Inc.SCTX | $15.69 | +1.86% | 450.77K | $291.64M | $13.50 - $39.60 | 0.00% |
| 74 | Agenus Inc.AGEN | $6.41 | +4.22% | 524.64K | $289.49M | $2.71 - $10.31 | 0.00% |
| 75 | SAB Biotherapeutics, Inc.SABS | $3.05 | +10.04% | 434.24K | $277.51M | $2.44 - $5.15 | 0.00% |
| 76 | Century Therapeutics, Inc.IPSC | $1.42 | +0.70% | 308.94K | $256.22M | $0.43 - $3.04 | 0.00% |
| 77 | Ocugen, Inc.OCGN | $0.74 | +5.60% | 6.28M | $251.62M | $0.70 - $2.73 | 0.00% |
| 78 | Fate Therapeutics, Inc.FATE | $2.06 | +0.97% | 693.29K | $247.43M | $0.95 - $3.23 | 0.00% |
| 79 | Cabaletta Bio, Inc.CABA | $1.42 | +4.81% | 4.55M | $239.91M | $1.32 - $4.23 | 0.00% |
| 80 | Lexeo Therapeutics, Inc.LXEO | $2.83 | +3.89% | 1.73M | $232.60M | $2.55 - $10.99 | 0.00% |
| 81 | Alector, Inc.ALEC | $2.06 | +14.48% | 3.86M | $229.45M | $1.09 - $2.76 | 0.00% |
| 82 | Inhibikase Therapeutics, Inc.IKT | $1.55 | +2.96% | 910.08K | $216.98M | $1.33 - $2.61 | 0.00% |
| 83 | Artiva Biotherapeutics, Inc.ARTV | $4.30 | -30.93% | 7.65M | $210.23M | $2.96 - $14.53 | 0.00% |
| 84 | Palisade Bio, Inc.PALI | $1.18 | -2.85% | 3.84M | $204.94M | $1.18 - $2.85 | 0.00% |
| 85 | Alpha Cognition Inc.ACOG | $8.85 | +6.99% | 137.12K | $192.63M | $4.50 - $10.14 | 0.00% |
| 86 | Precision BioSciences, Inc.DTIL | $6.71 | +4.68% | 91.11K | $185.21M | $3.53 - $9.62 | 0.00% |
| 87 | Invivyd, Inc.IVVD | $0.59 | +1.36% | 3.38M | $175.09M | $0.53 - $3.07 | 0.00% |
| 88 | Acumen Pharmaceuticals, Inc.ABOS | $2.29 | +3.08% | 1.48M | $165.97M | $1.50 - $3.60 | 0.00% |
| 89 | Coherus Oncology, Inc.CHRS | $1.05 | +4.46% | 383.05K | $163.00M | $0.94 - $2.62 | 0.00% |
| 90 | MaxCyte, Inc.MXCT | $1.55 | +2.98% | 1.27M | $160.49M | $0.64 - $1.80 | 0.00% |
| 91 | Protara Therapeutics, Inc.TARA | $2.44 | +4.04% | 1.43M | $144.37M | $2.27 - $7.82 | 0.00% |
| 92 | Sutro Biopharma, Inc.STRO | $8.46 | -3.49% | 280.89K | $140.28M | $7.15 - $43.85 | 0.00% |
| 93 | Compass Therapeutics, Inc.CMPX | $0.74 | -1.27% | 1.26M | $133.45M | $0.73 - $6.88 | 0.00% |
| 94 | Outlook Therapeutics, Inc.OTLK | $0.52 | +1.05% | 2.68M | $126.84M | $0.16 - $2.54 | 0.00% |
| 95 | Humacyte, Inc.HUMA | $0.44 | +10.28% | 3.16M | $122.79M | $0.34 - $1.78 | 0.00% |
| 96 | Anavex Life SciencesAVXL | $1.27 | -0.78% | 968.36K | $118.19M | $1.14 - $8.79 | 0.00% |
| 97 | Voyager Therapeutics, Inc.VYGR | $1.74 | -1.42% | 919.33K | $106.91M | $1.71 - $5.48 | 0.00% |
| 98 | enGene Therapeutics Inc.ENGN | $1.57 | -0.32% | 268.32K | $105.55M | $1.40 - $12.25 | 0.00% |
| 99 | Tevogen Inc.TVGN | $6.56 | +4.29% | 2.30K | $103.25M | $3.64 - $32.90 | 0.00% |
| 100 | Black Diamond Therapeutics, Inc.BDTX | $1.75 | +1.48% | 900.14K | $100.83M | $1.60 - $4.94 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。